During the trial, additional anti-diabetic medication was initiated as an add on to randomized treatment by 4.9%, 1.1 % and 2.2% of patients randomized to placebo, semaglutide tablets 7 mg and semaglutide tablets 14 mg, respectively
6.2 Postmarketing Experience Additional adverse reactions have been identified during postapproval use of JANUVIA as monotherapy and/or in combination with other antihyperglycemic agents
The fix: Even if solid food feels impossible, have a protein shake
Cmlapkp: Getty Images Szeptember elejtl brki szmra hozzfrhetv vlnak a krhzi fertzsek legfrissebb adatai
As the newest GLP-1 agonist, Mounjaro works in the same way as Ozempic/Wegovy and Saxenda but has an additional action that maximises insulin sensitivity, potential leading to added weight loss benefits
Use our dosage calculator for any dose